It is essential to conduct all pharmaceutical manufacturing processes in a safe manner. Equipped with the advanced instrument including RC1e, DSC, RSC, ARC, and TGA, PharmaBlock has a dedicated process safety team to collect comprehensive data and support all the HAZOP analysis, identify potential safety risks during scale up, and help chemists to optimize and prove the robustness of the process. Comprehensive safety evaluations usually begin immediately once a project is accepted and run parallel to process development activities.
PharmaBlock Process Safety Laboratory has been accredited by China National Accreditation Service for Conformity Assessment (CNAS) (Registration No.: CNAS L13658). The accreditation of the Process Safety Laboratory recognizes PharmaBlock’s capability and qualification to serve the process safety assessment needs in the area of pharmaceutical process development and manufacturing. CNAS is a national accreditation body responsible for accreditation of certification bodies and laboratories. It was established with the approval of the National Certification and Accreditation Administration of the People's Republic of China (CNCA). CNAS also cooperates with International Laboratory Accreditation Cooperation (ILAC), demonstrating its international prestige and recognition.
Click here to know more about our INSIGHTS & CASE STUDIES of process safety assessment